Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Advent firms up deal for Sanofi in Europe

Executive Summary

Advent International and Sanofi have struck a final deal for the private-equity investment group to acquire Sanofi’s European generics business, Zentiva, through a share purchase agreement worth €1.9 billion (US$2.2 billion). The deal comes after the completion of exclusive negotiations that were announced by the two companies in mid-April (Generics bulletin, 20 April 2018, page 1).

You may also be interested in...



Zentiva Invests €27m In Prague Plant

Zentiva has announced that it is investing a further €27m in expanding its flagship manufacturing plant in Prague, having already pumped €35m into the site over the past three years.

Zentiva Opens India Office As It Completes Ankleshwar Plant Deal

Zentiva is opening a dedicated Indian office in Mumbai to support the Ankleshwar manufacturing facility that it has just acquired from former parent company Sanofi.

Zentiva Buys Sanofi's Ankleshwar Site

Zentiva has struck a deal to acquire a manufacturing site in Ankleshwar, India, from its former parent company Sanofi.

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

GB000920

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel